Anthropic IPO valuation calculator: How much is it really worth?

The filing arrives as the artificial intelligence company moves toward a public offering, placing its valuation and the terms of that offering in view. The Financial Times has published an Anthropic IPO valuation calculator under the headline "Anthropic IPO valuation calculator: How much is it really worth?" The calculator format signals that the debate over the company's worth is being framed as a range of possible outcomes rather than a single settled figure.

Together, the three outlets approach the offering from different angles: the regulatory filing itself, the question of how the market will price the company, and the risk attached to restrictions on when early shareholders can sell.

The context a reader needs is that Anthropic's offering is being treated as a test of appetite for AI-related assets. Bloomberg's coverage explicitly describes a split between excitement and skepticism, which means the market's reaction is not one-directional. The lockup issue raised in Bloomberg's second report adds a second layer of concern beyond the headline valuation: if restrictions on selling shares create the risk of a later supply of stock, that could weigh on the sector. The Financial Times calculator, meanwhile, acknowledges that the valuation is uncertain enough to require scenarios. The SEC filing provides the formal document underlying the process, and its appearance on the SEC.gov feed confirms the amended registration statement is part of the public record.

What to watch next follows directly from the stated facts. The amended S-1/A-2 is the document to track for the terms of the offering, including any lockup provisions that Bloomberg's coverage flags as a source of correction risk. The valuation range implied by the Financial Times calculator will matter as investors weigh the company's worth against the enthusiasm and skepticism Bloomberg describes. Bloomberg's two reports also point to a near-term sequence: the market's initial reception of the IPO, and then the period when lockup restrictions begin to shape trading behavior. Coverage does not yet specify a target valuation, a share price, a listing date, or the size of the offering, so those details remain open.